Literature DB >> 20101619

Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation.

Nobuko Ishiura1, Hiroko Nakashima, Rei Watanabe, Yoshihiro Kuwano, Takahiro Adachi, Yoshimasa Takahashi, Takeshi Tsubata, Hitoshi Okochi, Kunihiko Tamaki, Thomas F Tedder, Manabu Fujimoto.   

Abstract

CD19 is a B-cell transmembrane molecule that is critical for B-cell activation. CD19 serves as a scaffold protein for key signal transduction molecules including Lyn, PI3K, and Vav, by providing docking sites for these molecules via phosphorylation of CD19-Y(513), CD19-Y(482), and CD19-Y(391). We investigated the process of CD19 tyrosine phophorylation during B-cell activation using Ab specific for each of these phosphorylated tyrosines. BCR engagement induced differential tyrosine phosphorylation, as CD19-Y(513) phophorylation occurred first, and CD19-Y(482) phosphorylation was delayed and transient. Different BCR isotypes exhibited distinct patterns of CD19 phosphorylation: IgG-BCR ligation resulted in faster phosphorylation of CD19-Y(513) and more intense phosphorylation of CD19-Y(391) than IgM-BCR ligation. This affected CD19-mediated downstream pathways involving Vav, PI3K, and Akt. Additionally, the phosphorylation profile of CD19 differed distinctly according to its plasma membrane location. CD19 phosphorylated at Y(513) was almost exclusively located within lipid rafts, whereas phosphorylated Y(482) and Y(391) were found both inside and outside of the rafts. Furthermore, the phosphorylation of all three tyrosines was remarkably enhanced and prolonged following the simultaneous stimulation of BCR and CD40. Thus, variations in phosphorylation patterns may contribute to the complexity of CD19-regulated signal transduction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101619     DOI: 10.1002/eji.200939848

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  Vitamin A and retinoic acid in the regulation of B-cell development and antibody production.

Authors:  A Catharine Ross; Qiuyan Chen; Yifan Ma
Journal:  Vitam Horm       Date:  2011       Impact factor: 3.421

2.  Agammaglobulinemia associated with BCR⁻ B cells and enhanced expression of CD19.

Authors:  A Kerry Dobbs; Amma Bosompem; Elaine Coustan-Smith; Gayle Tyerman; Frank T Saulsbury; Mary Ellen Conley
Journal:  Blood       Date:  2011-06-21       Impact factor: 22.113

3.  Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progression.

Authors:  J Boysen; M Nelson; G Magzoub; G P Maiti; S Sinha; M Goswami; S K Vesely; T D Shanafelt; N E Kay; A K Ghosh
Journal:  Leukemia       Date:  2016-08-02       Impact factor: 11.528

4.  Specificity and biologic activities of novel anti-membrane IgM antibodies.

Authors:  Rachel S Welt; Jonathan A Welt; David Kostyal; Yamuna D Gangadharan; Virginia Raymond; Sydney Welt
Journal:  Oncotarget       Date:  2016-11-15

5.  Co-engaging CD47 and CD19 with a bispecific antibody abrogates B-cell receptor/CD19 association leading to impaired B-cell proliferation.

Authors:  Eric Hatterer; Leticia Barba; Nelly Noraz; Bruno Daubeuf; Jean-Pierre Aubry-Lachainaye; Benoit von der Weid; Françoise Richard; Marie Kosco-Vilbois; Walter Ferlin; Limin Shang; Vanessa Buatois
Journal:  MAbs       Date:  2019-01-31       Impact factor: 5.857

Review 6.  Engineering enhanced CAR T-cells for improved cancer therapy.

Authors:  Michael C Milone; Jie Xu; Sai-Juan Chen; McKensie A Collins; Jianfeng Zhou; Daniel J Powell; J Joseph Melenhorst
Journal:  Nat Cancer       Date:  2021-08-19

7.  CD19: a biomarker for B cell development, lymphoma diagnosis and therapy.

Authors:  Kemeng Wang; Guoqing Wei; Delong Liu
Journal:  Exp Hematol Oncol       Date:  2012-11-29

8.  CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells.

Authors:  Christian B Schiller; Todd A Braciak; Nadja C Fenn; Ursula J E Seidel; Claudia C Roskopf; Sarah Wildenhain; Annemarie Honegger; Ingo A Schubert; Alexandra Schele; Kerstin Lämmermann; Georg H Fey; Uwe Jacob; Peter Lang; Karl-Peter Hopfner; Fuat S Oduncu
Journal:  Oncotarget       Date:  2016-12-13

9.  IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcγRIIB phosphorylation in glioblastoma.

Authors:  Yunmian Liu; Chunyan Song; Faping Shen; Jing Zhang; Sonya Wei Song
Journal:  PLoS One       Date:  2019-09-27       Impact factor: 3.240

10.  Transcriptome Profiling across Five Tissues of Giant Panda.

Authors:  Feng Li; Chengdong Wang; Zhongxian Xu; Mingzhou Li; Linhua Deng; Ming Wei; Hemin Zhang; Kai Wu; Ruihong Ning; Diyan Li; Mingyao Yang; Mingwang Zhang; Qingyong Ni; Bo Zeng; Desheng Li; Ying Li
Journal:  Biomed Res Int       Date:  2020-08-10       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.